KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Change in Accured Expenses (2016 - 2025)

Inovio Pharmaceuticals (INO) has disclosed Change in Accured Expenses for 16 consecutive years, with -$4.6 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 629.34% to -$4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.4 million through Dec 2025, down 84.76% year-over-year, with the annual reading at -$6.4 million for FY2025, 84.76% down from the prior year.
  • Change in Accured Expenses hit -$4.6 million in Q4 2025 for Inovio Pharmaceuticals, down from -$350130.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $27.3 million in Q3 2022 to a low of -$40.7 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged -$1.4 million across 5 years, with a median of -$49315.0 in 2021.
  • Biggest five-year swings in Change in Accured Expenses: surged 10812.27% in 2022 and later plummeted 274673.23% in 2023.
  • Year by year, Change in Accured Expenses stood at -$49315.0 in 2021, then soared by 10812.27% to $5.3 million in 2022, then fell by 11.92% to $4.7 million in 2023, then plummeted by 81.42% to $864312.0 in 2024, then tumbled by 629.34% to -$4.6 million in 2025.
  • Business Quant data shows Change in Accured Expenses for INO at -$4.6 million in Q4 2025, -$350130.0 in Q3 2025, and $2.7 million in Q2 2025.